首页 | 本学科首页   官方微博 | 高级检索  
检索        

培菲康佐治小儿反复呼吸道感染的临床观察
引用本文:佘志婉,张新玲,薛立军.培菲康佐治小儿反复呼吸道感染的临床观察[J].实用全科医学,2010,8(3):319-320.
作者姓名:佘志婉  张新玲  薛立军
作者单位:广东省深圳市宝安区松岗人民医院儿科,518000 
摘    要:目的探讨肠道菌群调节剂(培菲康)辅助治疗小儿反复呼吸道感染(RRI)的疗效,及其对T细胞亚群的影响。方法选择96例反复呼吸道感染的患儿,随机将患几分为两组,两组患儿急性期均给予常规治疗,治疗组在对照组常规治疗的基础上,加服培菲康,疗程为6个月。两组患儿均随访12个月,记录呼吸道感染情况、T细胞亚群(CD3、CD4、CD8)检测结果及不良反应。结果治疗组、对照组总有效率分别为91.3%、73.3%,总有效率比较差异有统计学意义(P〈0.05)。治疗组的呼吸道感染次数(t=9.09),发热天数(t=7.22)、咳嗽天数(t=7.58)均少于对照组,差异有统计学意义(P均〈0.01);治疗组在治疗后的CD3、CD4、CD4/CD8比值均升高(P均〈0.01),CD8降低(P〈0.01);对照组用药前、后CD3、CIM、CD8、CD4/CD8之值无显著性差异(P〉0.05)。结论培菲康对反复呼吸道感染患儿有免疫调节作用,对反复呼吸道感染急性发作可起到一定的预防作用。

关 键 词:反复呼吸道感染  培菲康  免疫  小儿

Clinical Study on Supplementary Treating Recurrent Respiratory Tract Infection by Bifico
SHE Zhi-wan,ZHANG Xin-ling,XUE Li-jun.Clinical Study on Supplementary Treating Recurrent Respiratory Tract Infection by Bifico[J].Applied Journal Of General Practice,2010,8(3):319-320.
Authors:SHE Zhi-wan  ZHANG Xin-ling  XUE Li-jun
Institution:SHE Zhi-wan,ZHANG Xin-ling,XUE Li-jun.Department of Pediatrics,Songgang People\'s Hospital of Baoan District in Shenzhen,Shenzhen 518000,Guangdong,China
Abstract:Objective To investigate the supplementary effect of Bifico on T lymphocyte subsets in children with recurrent respiratory tract infection.Methods 96 children with recurrent respiratory tract infection were randomly allocated into two groups:the treatment group received conventional treatment plus bifico and the control group received conventional treatment only.The episodes of RRI,the T lymphocyte subsets(CD3,CD4,CD8) measurements and the adverse events were recorded in the following 12 months.Results The ...
Keywords:Respiratory tract infection  Bifico  Immunity  Children  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号